The world's first 2 in 1 medicated food for cats.
A revolution in CKD treatment combining medication for proteinuria with renal nutrition
What is VikalyTM?
VikalyTM is a high-quality clinical diet specially formulated for cats with chronic kidney disease (CKD) including medication to manage proteinuria. It is a comprehensive, ready-to-use solution for CKD management, addressing both the cat’s nutritional and treatment needs.
VikalyTM is a convenient and effective all-in-one solution supported by numerous clinical studies
Highly palatable clinical renal formulation
Treatment for proteinuria11
Indication: support of renal function and reduction of proteinuria associated with chronic kidney disease.
Prescribing VikalyTM
VikalyTM is only available under vet prescription.
Check the following table as a guide to how many days a 1.5kg VikalyTM bag lasts according to the cat's daily requirements in grams:
The daily ration can be administered in several smaller meals throughout the day, to accommodate the individual preferences of the cat and promote consistent food intake.
If you recommend feeding VikalyTM in combination with a wet food, the owner should only give wet food after the cat has consumed at least 50% of their daily VikalyTM ration
Presentations Available
1.5kg Bags

Vikaly Medicated Complete Food for Cats (containing Benamix 6.25 mg/g Premix for Medicated Feeding Stuff for Cats) contains benazepril POM-V. Further information is available from the product datasheet or from: Virbac Limited, Woolpit Business Park, Windmill Avenue, Woolpit, Bury St Edmunds, Suffolk, IP30 9UP. Tel: 01359 243243 Email: enquiries@virbac.co.uk Web: uk.virbac.com
Prescription decisions are for the person issuing the prescription alone. Use Medicines Responsibly.
References: 11. Benamix premix summary of product characteristics; 13. Fortekor summary of product characteristics; 14. King et al. J Vet Intern Med. 2006;20(5):1054-1064.; 15. Mizutani et al. J Vet Intern Med. 2006;20(5):1074-1079.; 16. Watanabe & Mishina. J Vet Med Sci. 2007;69(10):1015-1023